Harmony Biosciences Holdings (HRMY)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021
Operating income (ttm)	US$ in thousands	192,030	199,447	146,839	133,053	120,186	101,204	110,356	100,552	87,529	66,656	55,983
Revenue (ttm)	US$ in thousands	548,499	507,747	476,532	451,378	419,060	383,158	319,980	290,957	268,890	236,824	233,336
Operating profit margin		35.01%	39.28%	30.81%	29.48%	28.68%	26.41%	34.49%	34.56%	32.55%	28.15%	23.99%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $192,030K ÷ $548,499K
= 35.01%

Harmony Biosciences Holdings Inc has exhibited fluctuating operating profit margins over the past eight quarters. The operating profit margins have ranged from a low of 25.25% in Q3 2022 to a high of 36.80% in Q3 2023. The average operating profit margin over this period is approximately 30.46%.

The company's operating profit margin demonstrates variability in profitability levels, with some quarters showing stronger performance compared to others. The increase in operating profit margin from Q1 2022 to Q3 2023 indicates improvements in cost management and revenue generation efficiency. However, the downward trend seen in Q4 2023 compared to the previous quarter could potentially signal challenges in maintaining profitability.

Analyzing the operating profit margin provides insights into the company's ability to control costs and generate profits from its core operations. Investors and stakeholders may closely monitor these fluctuations to assess the company's financial health and operational efficiency over time.